Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Alexander

Showing results (691-700 of 1,017) with videos related to

Pageof 102
Sort By:
Lancet (London, England)|September 21, 1991
Outbreak of paralytic poliomyelitis in Oman: evidence for widespread transmission among fully vaccinated childrenR W Sutter, P A Patriarca, S Brogan, et al.
Biochemistry|October 24, 2007
Novel mechanistic class of fatty acid amide hydrolase inhibitors with remarkable selectivityKyunghye Ahn, Douglas S Johnson, Laura R Fitzgerald, et al.
Kidney International|December 21, 2012
Membranous glomerulonephritis is a manifestation of IgG4-related diseaseMariam P Alexander, Christopher P Larsen, Ian W Gibson, et al.
Journal of the American Society of Nephrology : JASN|November 4, 2017
DnaJ Heat Shock Protein Family B Member 9 Is a Novel Biomarker for Fibrillary GNSurendra Dasari, Mariam P Alexander, Julie A Vrana, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|August 29, 2020
Treatment of older patients with atrial fibrillation by morbidity burdenPeter Vibe Rasmussen, Jannik Langtved Pallisgaard, Morten Lock Hansen, et al.
Eye (London, England)|October 6, 2021
Stickler syndrome - lessons from a national cohortM P Snead, A J Richards, A M McNinch, et al.
Trials|April 11, 2020
Methods for safety and endpoint ascertainment: identification of adverse events through scrutiny of negatively adjudicated eventsAlexander C Fanaroff, Ghazala Haque, Betsy Thomas, et al.
Journal of the American Heart Association|April 26, 2017
Reporting Clinical End Points and Safety Events in an Acute Coronary Syndrome Trial: Results With Integrated CollectionPatrícia O Guimarães, Renato D Lopes, Susanna R Stevens, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 22, 2001
Investigation of the in vitro metabolism profile of a phosphodiesterase-IV inhibitor, CDP-840: leading to structural optimizationC Li, N Chauret, L A Trimble, et al.
Archives of Internal Medicine|August 10, 2011
Diagnostic blood loss from phlebotomy and hospital-acquired anemia during acute myocardial infarctionAdam C Salisbury, Kimberly J Reid, Karen P Alexander, et al.
Pageof 102

Showing results (691-700 of 1,017) with videos related to

Sort By:
Pageof 102
Lancet (London, England)|September 21, 1991
Outbreak of paralytic poliomyelitis in Oman: evidence for widespread transmission among fully vaccinated childrenR W Sutter, P A Patriarca, S Brogan, et al.
Biochemistry|October 24, 2007
Novel mechanistic class of fatty acid amide hydrolase inhibitors with remarkable selectivityKyunghye Ahn, Douglas S Johnson, Laura R Fitzgerald, et al.
Kidney International|December 21, 2012
Membranous glomerulonephritis is a manifestation of IgG4-related diseaseMariam P Alexander, Christopher P Larsen, Ian W Gibson, et al.
Journal of the American Society of Nephrology : JASN|November 4, 2017
DnaJ Heat Shock Protein Family B Member 9 Is a Novel Biomarker for Fibrillary GNSurendra Dasari, Mariam P Alexander, Julie A Vrana, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|August 29, 2020
Treatment of older patients with atrial fibrillation by morbidity burdenPeter Vibe Rasmussen, Jannik Langtved Pallisgaard, Morten Lock Hansen, et al.
Eye (London, England)|October 6, 2021
Stickler syndrome - lessons from a national cohortM P Snead, A J Richards, A M McNinch, et al.
Trials|April 11, 2020
Methods for safety and endpoint ascertainment: identification of adverse events through scrutiny of negatively adjudicated eventsAlexander C Fanaroff, Ghazala Haque, Betsy Thomas, et al.
Journal of the American Heart Association|April 26, 2017
Reporting Clinical End Points and Safety Events in an Acute Coronary Syndrome Trial: Results With Integrated CollectionPatrícia O Guimarães, Renato D Lopes, Susanna R Stevens, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 22, 2001
Investigation of the in vitro metabolism profile of a phosphodiesterase-IV inhibitor, CDP-840: leading to structural optimizationC Li, N Chauret, L A Trimble, et al.
Archives of Internal Medicine|August 10, 2011
Diagnostic blood loss from phlebotomy and hospital-acquired anemia during acute myocardial infarctionAdam C Salisbury, Kimberly J Reid, Karen P Alexander, et al.
Pageof 102